Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Culler

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Investigation|February 15, 1997
Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulationI Shimon, J E Taylor, J Z Dong, et al.
European Journal of Clinical Investigation|August 19, 2007
In vitro antiangiogenic activity of selective somatostatin subtype-1 receptor agonistsG Bocci, M D Culler, A Fioravanti, et al.
European Journal of Endocrinology|December 14, 2004
Novel ghrelin analogs with improved affinity for the GH secretagogue receptor stimulate GH and prolactin release from human pituitary cellsH Rubinfeld, M Hadani, J E Taylor, et al.
Endocrinology|March 18, 2003
Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activitiesT Florio, M Morini, V Villa, et al.
The Journal of Clinical Endocrinology and Metabolism|February 26, 2000
Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypesP Jaquet, A Saveanu, G Gunz, et al.
American Journal of Obstetrics and Gynecology|April 1, 1987
The ovarian renin-angiotensin system: renin-like activity and angiotensin II/III immunoreactivity in gonadotropin-stimulated and unstimulated human follicular fluidA Lightman, B C Tarlatzis, P J Rzasa, et al.
Journal of Molecular Endocrinology|October 12, 2005
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitroM C Zatelli, D Piccin, F Tagliati, et al.
Human Reproduction (Oxford, England)|January 1, 1995
Gonadotrophin surge-attenuating factor bioactivity is present in follicular fluid from naturally cycling womenP A Fowler, U Fahy, M D Culler, et al.
Peptides|January 1, 1981
In vivo and in vitro release of ACTH by synthetic CRFC M Turkelson, A Arimura, M D Culler, et al.
Molecular and Cellular Endocrinology|November 12, 2013
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growthM Ruscica, P Magni, L Steffani, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Investigation|February 15, 1997
Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulationI Shimon, J E Taylor, J Z Dong, et al.
European Journal of Clinical Investigation|August 19, 2007
In vitro antiangiogenic activity of selective somatostatin subtype-1 receptor agonistsG Bocci, M D Culler, A Fioravanti, et al.
European Journal of Endocrinology|December 14, 2004
Novel ghrelin analogs with improved affinity for the GH secretagogue receptor stimulate GH and prolactin release from human pituitary cellsH Rubinfeld, M Hadani, J E Taylor, et al.
Endocrinology|March 18, 2003
Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activitiesT Florio, M Morini, V Villa, et al.
The Journal of Clinical Endocrinology and Metabolism|February 26, 2000
Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypesP Jaquet, A Saveanu, G Gunz, et al.
American Journal of Obstetrics and Gynecology|April 1, 1987
The ovarian renin-angiotensin system: renin-like activity and angiotensin II/III immunoreactivity in gonadotropin-stimulated and unstimulated human follicular fluidA Lightman, B C Tarlatzis, P J Rzasa, et al.
Journal of Molecular Endocrinology|October 12, 2005
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitroM C Zatelli, D Piccin, F Tagliati, et al.
Human Reproduction (Oxford, England)|January 1, 1995
Gonadotrophin surge-attenuating factor bioactivity is present in follicular fluid from naturally cycling womenP A Fowler, U Fahy, M D Culler, et al.
Peptides|January 1, 1981
In vivo and in vitro release of ACTH by synthetic CRFC M Turkelson, A Arimura, M D Culler, et al.
Molecular and Cellular Endocrinology|November 12, 2013
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growthM Ruscica, P Magni, L Steffani, et al.
Pageof 9